Differences in Tumor-Infiltrating Lymphocyte Counts in the Peritumoral Area in Patients Undergoing Hepatic Resection after Lenvatinib and Atezolizumab Plus Bevacizumab Therapy for Hepatocellular Carcinoma.
Cancer medicine（2025）
关键词
atezolizumab plus bevacizumab,conversion surgery,hepatocellular carcinoma,lenvatinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要